Surmount 4 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Surmount 4. Real-time updates on events, politics, business and more.

SURMOUNT-4: Tirzepatide Withdrawal Linked to 20 Percentage-Point Weight Gain

December 11, 2023

Phase 3 data show patients with obesity who maintained tirzepatide from weeks 36 to 88 continued significant weight loss versus patients switched to placebo.

Jeff Emmick Louisj Aronne Division Of Endocrinology Weight Control Center Comprehensive Weight Control Center Weill Cornell Medicine

Source: hcplive.com

Diabetes Dialogue: SURMOUNT-3 and -4 Inform Use of Tirzepatide in Obesity

October 27, 2023

In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US Food and Drug Administration for chronic weight management.

Eli Lilly Natalie Bellini Diana Isaacs Provention Bio Diabetes Technology At University Hospitals Training In Diabetes Technology

Source: hcplive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Surmount 4 News Today

SURMOUNT-4: Tirzepatide Withdrawal Linked to 20 Percentage-Point Weight Gain

Diabetes Dialogue: SURMOUNT-3 and -4 Inform Use of Tirzepatide in Obesity

Explore More Categories